High levels of pSer153 RKIP are induced by IL-6 and H. pylori infection in colon and gastric cancers, respectively, and are associated with a poor prognosis in stage II colon cancer patients and little to no response to therapy for patients with multiple myeloma [57,60,61]. Here, PEBP1 is linked to gastric cancer.